Hermetica Superfood Encyclopedia
The Short Answer
Shimi root bark contains iboga-class alkaloids — principally ibogaine, tabernaemontanine, and rauwolscine — which modulate opioid receptors, adrenergic pathways, and inflammatory mediator cascades to produce analgesic, psychoactive, and anti-inflammatory effects. Preclinical data from closely related Tabernaemontana species demonstrate up to 97% reduction in myeloperoxidase activity and significant suppression of pro-inflammatory cytokines IL-1β, TNF-α, and MIP-2 in mouse edema models, though no human clinical trials for T. undulata itself have been completed.
CategoryRoot
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordShimi Tabernaemontana undulata benefits
Shimi — botanical close-up
Health Benefits
**Ocular Inflammation Relief**
Tabernaemontanine exerts analgesic and anti-inflammatory effects on ocular tissues; traditional eye-drop preparations are used to reduce inflammation, sharpen visual acuity, and alleviate eye pain in Amazonian communities.
**Pain and Headache Attenuation**
Tabernaemontanine modulates analgesic pathways to address muscular pain and headaches; its anti-inflammatory action likely involves suppression of prostaglandin-mediated nociception similar to mechanisms observed across the Tabernaemontana genus.
**Cognitive Clarity and Alertness**
Rauwolscine, an alpha-2 adrenoceptor antagonist present in the root bark, enhances noradrenergic tone, promoting mental focus, alertness, and emotional stability at low doses.
**Antimicrobial Activity**: Monoterpene indole alkaloids within T
undulata root bark disrupt bacterial and fungal cell membrane integrity; related Tabernaemontana species show broad-spectrum antimicrobial activity against Gram-positive and Gram-negative pathogens in vitro.
**Opioid Modulation and Addiction Support**
Ibogaine interacts with opioid receptors and sigma receptors, attenuating withdrawal symptoms and cravings; iboga alkaloids from related species have been investigated as adjuncts in opiate detoxification protocols.
**Anti-inflammatory Cascade Suppression**
Indole alkaloids from Tabernaemontana species inhibit key inflammatory mediators including MPO activity, MIP-2, IL-1β, and TNF-α, preventing leukocyte infiltration and edema formation in preclinical models.
**Ceremonial and Psychospiritual Facilitation**
Ibogaine and related alkaloids produce altered states of consciousness used in visionary and shamanic healing contexts; low-dose preparations are traditionally employed to enhance perceptual acuity and spiritual clarity during ritual practices.
Origin & History
Natural habitat
Tabernaemontana undulata is native to the Amazon rainforest basin, distributed across Brazil, Peru, Colombia, and neighboring Amazonian nations, where it grows as a shrub or small tree in humid tropical understory environments. The plant thrives in fertile, well-drained forest soils at low to moderate elevations and is predominantly harvested from wild populations rather than cultivated. Indigenous communities including the Katukina and Matsés have sustainably harvested its root bark for generations as part of traditional shamanic and medicinal practice.
“Tabernaemontana undulata has been integral to Amazonian shamanic medicine for centuries, used by indigenous groups including the Katukina, Matsés, and neighboring tribes of the Brazilian and Peruvian Amazon as a tool for spiritual purification, visionary healing ceremonies, and physical treatment of pain and eye ailments. The plant is referred to as 'Shimi' or 'Sananga' across different regional linguistic traditions, and its eye-drop application is particularly prominent among hunting cultures, where enhanced night vision and ocular sharpness are of practical and ceremonial importance. Sacred preparation protocols — often involving prayers, fasting, and specific harvest timing — reflect the plant's status as a living spiritual ally rather than merely a medicinal substance within these traditions. The ibogaine content places Shimi within a broader pan-Amazonian and Central African pharmacological tradition of iboga-type plants used for rites of passage, addiction healing, and visionary states, though T. undulata's use remains regionally specific and has not historically intersected with the West African iboga (Tabernanthe iboga) tradition directly.”Traditional Medicine
Scientific Research
No peer-reviewed human clinical trials specific to Tabernaemontana undulata have been published in available literature, representing a significant evidence gap for this species. Preclinical evidence from the closely related T. catharinensis demonstrates statistically significant topical anti-inflammatory activity in murine ear-edema models, with extract treatment achieving 42–97% reduction in myeloperoxidase activity and measurable suppression of MIP-2, IL-1β, and TNF-α compared to vehicle controls, with indomethacin and dexamethasone used as positive comparators. Genus-level reviews have documented anticancer, antidiabetic, and antimicrobial activities across multiple Tabernaemontana species, but study designs are predominantly in vitro or small-animal models with limited translational validation. The ibogaine component has received the most independent pharmacological investigation, primarily in the context of opioid use disorder, but this research applies to the isolated compound rather than T. undulata whole-plant extracts specifically.
Preparation & Dosage
Traditional preparation
**Traditional Eye Drops**
Fresh root bark is pressed or juiced to yield a liquid that is diluted and instilled directly into the eyes; no standardized dilution ratio has been established clinically, and preparation potency varies by bark age and extraction method.
**Oral Decoction/Tea**
5–10 g of root bark per preparation, though this is unstandardized
Dried or fresh root bark shreds are simmered in water to produce a decoction consumed orally for pain, inflammation, and ceremonial use; commercial preparations suggest approximately .
**Root Bark Extract (Commercial)**
100 g packs) for self-preparation of teas or extracts; no pharmaceutical-grade standardization percentages for ibogaine or total alkaloid content have been established for T
Available as crude root bark shreds (e.g., . undulata products.
**Ceremonial/Shamanic Use**
Administered under supervision of trained indigenous practitioners (payés or healers) at ceremony-specific doses; quantities are determined by healer discretion based on participant weight, intention, and experience.
**Timing Note**
Eye-drop applications are typically performed at night or in low-light conditions to enhance the reported visual-sharpening effect; oral preparations are consumed in fasting ceremonial contexts.
**No Validated Clinical Dose**
No effective dose range has been established in clinical trials for T. undulata; all dosing guidance derives from ethnobotanical reports and traditional practice, not pharmacokinetic or safety studies.
Nutritional Profile
Tabernaemontana undulata root bark is not consumed as a macronutrient source and provides negligible caloric, protein, fat, or carbohydrate content in the quantities typically used medicinally. Its pharmacological significance derives entirely from its secondary metabolite alkaloid fraction, dominated by monoterpene indole alkaloids: ibogaine (psychoactive iboga-class alkaloid), tabernaemontanine (anti-inflammatory indole alkaloid), and rauwolscine (yohimbane-class alpha-2 antagonist); precise alkaloid concentrations in T. undulata root bark have not been published in peer-reviewed quantitative analyses. Related Tabernaemontana species (e.g., T. catharinensis) also contain voacangine, coronaridine, and ibogamine as minor alkaloids, which may similarly be present in T. undulata. Phenolic compounds and terpenes likely contribute antioxidant activity, as demonstrated in genus-level studies, but their quantitative presence in T. undulata has not been characterized. Bioavailability of alkaloids is expected to vary substantially depending on preparation method (aqueous decoction vs. direct juice), pH of preparation medium, and route of administration (ocular vs. oral).
How It Works
Mechanism of Action
Ibogaine, the principal psychoactive alkaloid, acts as a noncompetitive antagonist at NMDA glutamate receptors, a sigma-1 receptor agonist, and a modulator of mu- and kappa-opioid receptors, collectively attenuating withdrawal signaling and producing dissociative psychoactive effects. Rauwolscine functions as a selective alpha-2 adrenoceptor antagonist, disinhibiting norepinephrine release in the prefrontal cortex and limbic system, thereby enhancing arousal, focus, and lipolytic activity. Tabernaemontanine suppresses cyclooxygenase-mediated arachidonic acid metabolism and inhibits downstream inflammatory cytokine production — including TNF-α, IL-1β, and MIP-2 — reducing neutrophil recruitment and tissue edema in a manner consistent with the genus-wide anti-inflammatory pharmacology documented in T. catharinensis. Monoterpene indole alkaloids across the genus additionally disrupt microbial membrane potential and inhibit bacterial efflux pumps, contributing to observed antimicrobial effects.
Clinical Evidence
Clinical evidence for Tabernaemontana undulata as a whole-plant preparation is absent at the human trial level; all substantive clinical-grade data are derived from related species or the isolated compound ibogaine studied independently. Preclinical T. catharinensis studies demonstrate robust topical anti-inflammatory outcomes (42–97% MPO inhibition) in murine models, but species-specific extrapolation to T. undulata requires caution. Ibogaine as an isolated alkaloid has been evaluated in observational studies and small open-label trials for opioid dependence, showing reductions in withdrawal severity, but these findings are not attributable to T. undulata preparations directly. Overall confidence in clinical benefit claims for Shimi specifically remains low, grounded primarily in traditional ethnobotanical use and genus-level mechanistic plausibility rather than controlled human data.
Safety & Interactions
Ibogaine carries a well-documented cardiac safety concern at elevated doses, including QTc interval prolongation and risk of fatal arrhythmia, which must be considered when evaluating any ibogaine-containing botanical even in traditional preparations; low-dose traditional use has not been associated with reported fatalities in the ethnobotanical literature, but systematic safety monitoring has not been conducted. Rauwolscine's alpha-2 adrenoceptor antagonism may produce hypertension, tachycardia, and anxiety at higher concentrations, and could potentiate the cardiovascular effects of stimulants or sympathomimetic drugs. Ibogaine is contraindicated with MAOIs (risk of serotonin syndrome), opioids (complex receptor interaction and unpredictable withdrawal modulation), antiarrhythmics, and medications that prolong the QT interval; these contraindications should be extrapolated to T. undulata preparations given their ibogaine content. Use in pregnancy and lactation is contraindicated based on the psychoactive and potentially oxytocic alkaloid profile; individuals with pre-existing cardiac conditions, liver disease, or psychiatric disorders should avoid this plant, and long-term safety data for any form of T. undulata consumption remain entirely absent from the published literature.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Tabernaemontana undulataSanangaShimiAmazonian eye drops plantApocynaceae iboga shrub
Frequently Asked Questions
What is Shimi (Tabernaemontana undulata) used for traditionally?
Indigenous Amazonian peoples including the Katukina and Matsés traditionally use Shimi root bark as eye drops to sharpen vision, enhance night vision for hunting, and facilitate spiritual clarity during shamanic ceremonies. The plant is also used orally as a decoction for pain relief, headache treatment, and anti-inflammatory purposes, with its ibogaine and tabernaemontanine alkaloids considered the primary bioactive drivers of these effects.
Does Shimi contain ibogaine and is it safe?
Yes, Shimi root bark contains ibogaine, an iboga-class alkaloid with psychoactive, opioid-modulating, and analgesic properties. Ibogaine carries known cardiac risks including QTc prolongation at higher doses, is contraindicated with MAOIs, opioids, and antiarrhythmic drugs, and should never be used by individuals with pre-existing heart conditions; no standardized safe dose for T. undulata preparations has been established in clinical research.
What are the active alkaloids in Tabernaemontana undulata root bark?
The principal bioactive alkaloids in T. undulata root bark are ibogaine (psychoactive, opioid receptor modulator), tabernaemontanine (anti-inflammatory and analgesic), and rauwolscine (alpha-2 adrenoceptor antagonist that enhances noradrenergic tone and mental alertness). Related Tabernaemontana species also contain voacangine, coronaridine, and ibogamine, which may be present in T. undulata but have not been quantitatively confirmed in peer-reviewed analysis of this specific species.
Are there clinical trials supporting the use of Sananga or Shimi eye drops?
No human clinical trials have been published specifically for Tabernaemontana undulata or its eye-drop preparations as of available literature. Preclinical evidence from the related species T. catharinensis shows significant anti-inflammatory activity in mouse models — including 42–97% reduction in myeloperoxidase activity — but this data cannot be directly applied to T. undulata without species-specific clinical investigation.
How is Shimi prepared and what dose is used?
Traditionally, Shimi root bark is either freshly pressed into a juice for eye-drop application or boiled into an oral decoction; commercial sources offer dried root bark shreds in approximately 100 g quantities, but no clinically validated or standardized dose exists. All dosing in traditional contexts is determined by indigenous healers based on ceremonial intent and individual factors, and self-administration — particularly of eye drops — should be approached with extreme caution given the lack of safety data and the potent alkaloid content.
Is Shimi safe to use during pregnancy or while breastfeeding?
Shimi (Tabernaemontana undulata) should be avoided during pregnancy and breastfeeding due to insufficient safety data and the presence of alkaloids that may cross the placental barrier or enter breast milk. Traditional use in Amazonian communities does not establish safety for these vulnerable populations, and no clinical studies have evaluated reproductive safety. Pregnant or nursing individuals should consult a healthcare provider before considering any Shimi preparations.
Does Shimi interact with common medications, particularly pain relievers or anti-inflammatory drugs?
Shimi contains alkaloids like tabernaemontanine that modulate analgesic pathways, which may potentiate the effects of NSAIDs, opioids, or other pain medications, increasing the risk of adverse effects or toxicity. Additionally, the alkaloid content may interact with medications metabolized by hepatic cytochrome P450 enzymes, though specific interaction studies are limited. Concurrent use with pharmaceutical pain relievers or anti-inflammatory drugs should only be done under medical supervision to avoid unexpected interactions.
What is the difference between using Shimi as an eye drop versus taking it orally for systemic pain relief?
Shimi eye drops (Sananga) deliver alkaloids directly to ocular tissues, producing localized anti-inflammatory and analgesic effects with minimal systemic absorption, making them suitable for eye-specific complaints like inflammation and vision clarity. Oral preparations would result in systemic distribution of alkaloids throughout the body, potentially addressing generalized muscular pain and headaches but with greater risk of systemic side effects and hepatic metabolism. The topical ocular route is considered safer for localized eye conditions, while oral administration may be used in traditional contexts for broader pain management, though the latter carries higher risks and lower clinical validation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w shimi-tabernaemontana-undulata curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
